Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease

Je G., Kyong Soo Park · Movement Disorders · 2011

Summary

To determine progression and prognostic factors of progression rate of motor impairment, disability, and quality of life (QoL) in patients with newly diagnosed Parkinson's disease, a large number of patients are newly diagnosed with the disease.

Type: article
Published: 2011-02-15
Cited by: 93
References: 32
DOI: https://doi.org/10.1002/mds.23467
PubMed: https://pubmed.ncbi.nlm.nih.gov/21312273/
OpenAlex: https://openalex.org/W21312273
Semantic Scholar: https://api.semanticscholar.org/CorpusID:20645545

Keywords

Autopsy, Anencephaly, Pathological, Medicine, Pathology

References

Levodopa and the progression of Parkinson's disease.The Parkinson Study Group — 2004
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030E. Ray Dorsey, Radu Constantinescu, James P. Thompson — 2007
Alzheimer's disease and Parkinson's diseaseJeffrey L. Cummings, Adam Darkins, Mario F. Mendez — 1988
No Adjustments Are Needed for Multiple ComparisonsKenneth J. Rothman — 1990
Predictors and course of health‐related quality of life in Parkinson's diseaseElin Bjelland Forsaa, Jan Petter Larsen, Tore Wentzel‐Larsen — 2008
The validity of the Hospital Anxiety and Depression Scale. An updated literature review.Ingvar Bjelland, Alv A. Dahl, Tone Tangen Haug — 2002
Predictors of deterioration in health‐related quality of life in Parkinson's disease: Results from the DATATOP trialConnie Marras, Michael McDermott, Paula A. Rochon — 2008
Diagnostic criteria for Parkinson disease.Douglas J. Gelb, Eugene Oliver, Sid Gilman — 1999
Progression of motor impairment and disability in Parkinson diseaseGuido Alves, Tore Wentzel‐Larsen, Dag Aarsland — 2005
Rate of clinical progression in Parkinson's disease. A prospective studyAnette Schrag, Richard Dodel, Annika Spottke — 2007
How common are the “common” neurologic disorders?Adam Kaplin, Montel Williams — 2007
CUMULATIVE ILLNESS RATING SCALEBernard S. Linn, Margaret W. Linn, Lee Gurel — 1968
Predicting motor decline and disability in Parkinson disease: a systematic review.Connie Marras, Paula A. Rochon, Anthony E. Lang — 2002
Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study.Martin Reuther, EA Spottke, Jens Klotsche — 2007
Evaluation of the Hospital Anxiety and Depression Scale in Patients With Parkinson's DiseaseJohan Marinus, Albert F.G. Leentjens, Martine Visser — 2002
Determinants of disability and quality of life in mild to moderate Parkinson diseaseD. Muslimović, Bart Post, Johannes D. Speelman — 2008
ParkinsonismMargaret M. Hoehn, Melvin D. Yahr — 1967
The AMC Linear Disability Score in patients with newly diagnosed Parkinson diseaseNadine Weisscher, Bart Post, Rob J. de Haan — 2007
Influence of clinical and demographic variables on quality of life in patients with Parkinson’s diseaseKenneth H. Karlsen, Jan Larsen, Elise Tandberg — 1999
Clinical heterogeneity in newly diagnosed Parkinson’s diseaseBart Post, Johannes D. Speelman, Rob J. de Haan — 2008

Cited by

La maladie de Parkinson de début tardif : différences et similitudes par rapport à celle des sujets plus jeunes ?Gilles Fénelon, J.‐P. Brandel — 2012
Behavioral impairments and serotonin reductions in rats after chronic L-dopaBranden J. Stansley, Bryan K. Yamamoto — 2015
Non-motor and neuropsychiatric features of Parkinson's diseaseDA Gallagher — 2013
A Practical Approach to Successful Longitudinal and Remote Follow-up of Parkinson's Disease: the FOUND StudyCaroline M. Tanner, Cheryl Meng, Bernard Ravina — 2014
Improved nutritional status is related to improved quality of life in Parkinson’s diseaseJamie M. Sheard, Susan Ash, George D. Mellick — 2014
Longitudinal study of levodopa in Parkinson's disease: Effects of the advanced disease phaseGanga Ganesvaran, Jane Alty, Benjamin Clissold — 2013
Parkinson's disease: diagnostic criteria, risk factors and progression, and assessment scales clinical stageAracelly Castro Toro, Omar Buriticá — 2014
The Complexities of Hormonal Influences and Risk of Parkinson’s DiseaseConnie Marras, Rachel Saunders‐Pullman — 2014
Spinal cord stimulation for Parkinson’s disease: a systematic reviewEmerson Magno de Andrade, Maria Gabriela Ghilardi, Rubens Gisbert Cury — 2015
Cognitive change in Parkinson's diseaseM. Broeders — 2015
Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson’s diseaseMegan K Young, Shu‐Kay Ng, George D. Mellick — 2013
Impact of nonmotor symptoms on disability in patients with Parkinson’s diseaseAlberto Raggi, Matilde Leonardi, F. Carella — 2011
What predicts cognitive decline in de novo Parkinson's disease?Dario Arnaldi, Claudio Campus, Michela Ferrara — 2012
Amantadine improves gait in PD patients with STN stimulation.Hiu-Fai Chan, Prashanth Lingappa Kukkle, Marcelo Merello — 2013
Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PDDaan C. Velseboer, Mark Broeders, Bart Post — 2013
Natural History of Parkinson's Disease in the Province of Segovia: Disability in a 20 Years Longitudinal StudyJ. Duarte, Luis Miguel García Olmos, Amelia Mendoza — 2015
Segmental progression of cardinal motor symptoms in Parkinson's disease: a pilot study suggesting a practical approach to rate disease course in the early stages.Marina Picillo, Marianna Amboni, Roberto Erro — 2013
Advanced Parkinson's disease: clinical characteristics and treatment. Part II.Jaime Kulisevsky, M. R. Luquín, José Matías Arbelo — 2013
How will epidemiology shape our knowledge of the patterns of disease progression in Parkinson’s disease?Connie Marras — 2012
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson’s diseaseMarina Picillo, Roberto Erro, Gabriella Santangelo — 2013

Related papers

No related papers recorded.